GenoScreen is a partner in collaborative research projects that bring together startups, multinationals and public-sector organizations. Our R&D teams provide their knowledge and expertise in the molecular microbiology of isolated agents and complex communities. This allowed our teams to develop our own projects for elaborating innovative products and services.

Our projects are designed to:

  • Improve the diagnosis and management of acute/chronic diseases on humans and animals.
  • Characterize and monitor microbial biodiversity, with applications in agronomy, agrifood and environment.

The common feature of these projects is the development of molecular tools for the characterization, monitoring and diagnosis of microbial communities. The key objective is to market simple analytical solutions and (ultimately) preventive, corrective or even therapeutic products based on microorganisms.

The BIMM-SOL project (2016-2018)

The goal of this project is to commercialize processes for analyzing molecular microbial biomarkers in the qualitative biological diagnosis of soils.

Funding:

ADEME

The DIAMA project (2016–2021)

The DIAMA project is assessing and validating the Deeplex®-MycTB test in Africa and Europe. This rapid molecular test (based on mass sequencing) detects and genotypes mycobacteria and predicts antituberculosis drug resistance in Mycobacterium tuberculosis complex strains.

Partners:

  • Centre National Hospitalier de Pneumo-Phtisiologie - Benin
  • Prins Leopold Instituut voor Tropische Geneeskunde – Belgium
  • Université des Sciences, des Techniques et des Technologies de Bamako (USTTB) – Mali
  • London School of Hygiene and Tropical Medicine (LSHTM) – UK
  • Service de Pneumophtisiologie de l’Hôpital National Ignace Deen – Guinea
  • Jimma University – Ethiopia
  • Université Catholique de Louvain (UCL) – Belgium
  • The Bamenda Center for Health Promotion and Research – Cameroun
  • Institute National of Research Biomedical of Zaire (INRB) – Congo
  • Damien Foundation – Belgium
  • Rwanda Biomedical Center (RBC) – Rwanda
  • University Cheikh Anta Diop – Senegal
  • World Health Organization

Funding:

horizon2020

The FLU-MICROBIOT project (2015–2018)

The goal of this project is to understand the role of microbiotas and the gastrointestinal and respiratory tracts in influenza co-infections.

Partners:

  • INSERM - CNRS - University of Lille 1 - Institut Pasteur of Lille,
  • Minas Gerais Federal University (Brazil)

Funding:

bpifrance

The BioDISSPOL project (2015–2018)

Development of microbial biomarkers for the identification and monitoring of sites polluted by chlorinated solvents.

Partners:

  • BRGM
  • University of Strasbourg

Funding:

ADEME

The MICROTYPE project (2014–2018)

This project underpins the worldwide surveillance of infectious agents like Brucella (the bacterium responsible for brucellosis) via the development of typing kits and databases.

Partners:

INRA UMR 1282 - ISP - INRA -François Rabelais University of Tours, and UPsud UNIVERSITE DE PARIS-SUD XI

Funding:

logo de la direction generale de l armement dga largelogo anr

By continuing your visit to this site, you accept the use of statistics cookies
More information I accept